BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Pseudomonas infection
,
Adipose tissue
,
Laryngoscope
,
Fluoxetine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nectin 4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Oral mucosa
Esophagus
Pharyngeal mucosa
Nipple cross-section
Vulva
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Barrett's esophagus
Esophagitis
Infestation by Ixodidae
Disorder of mucous membrane
Fetal growth restriction
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
A 771726
tert-Butylhydroperoxide
Dichlororibofuranosylbenzimidazole
nutlin-3A
Melphalan
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FAM198B-AS1
NSUN6
MYH7B
TEX10
GAS1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance.
Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
Nectin-4 has emerged as a compelling target for breast cancer.
NECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime?
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Early Onset Preeclampsia and Nectin-4
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Solid Tumor Malignancies
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That…
Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ